NIH-funded research R01 grant

Improving fracture healing in patients with diabetes

Official title: Treatment and Mechanisms of Diabetic Fracture Healing

Funded at University of Pennsylvania · NIH-11018585 · Data updated 2026-11-12

This study is looking at how diabetes can slow down the healing of broken bones and is testing a new way to help improve healing by using a special gel that releases a growth factor, focusing on a protein called FOXO1 and tiny structures in bone cells that are important for recovery.

More Fracture research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startApril 1, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$491,434
NIH project number5R01AR080895-03
Project IDNIH-11018585 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults with diabetes who have experienced bone fractures.

Less likely to help

Patients without diabetes or those who have not sustained bone fractures may not benefit from this research.

What this research studies

This research investigates how diabetes affects the healing of bone fractures and explores new strategies to enhance this process. The study focuses on the role of a specific protein, FOXO1, and the presence of cellular structures called cilia in bone cells, which are crucial for proper healing. By using a specially designed hydrogel that releases a growth factor, the researchers aim to improve the healing outcomes for diabetic patients with fractures. The approach includes both laboratory testing and advanced imaging techniques to assess healing progress.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for fracture healing in diabetic patients, reducing complications and enhancing recovery.

How similar studies have gone: Other research has shown promising results in enhancing fracture healing through targeted molecular approaches, suggesting potential for success in this novel investigation.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Yang, Shuying — University of Pennsylvania
  • Study coordinator: Yang, Shuying

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.